Pulmonx Corp. (LUNG)
1.83
-0.05
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
1.82
-0.01
(-0.55%)
After-Hours: 20:00
Pulmonx Net Income (Quarterly) : -10.08M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.08M |
| March 31, 2026 | -13.65M |
| December 31, 2025 | -10.42M |
| September 30, 2025 | -13.96M |
| June 30, 2025 | -15.17M |
| March 31, 2025 | -14.45M |
| December 31, 2024 | -13.18M |
| September 30, 2024 | -14.14M |
| June 30, 2024 | -15.33M |
| March 31, 2024 | -13.75M |
| December 31, 2023 | -13.89M |
| September 30, 2023 | -14.90M |
| June 30, 2023 | -16.20M |
| March 31, 2023 | -15.86M |
| December 31, 2022 | -14.28M |
| Date | Value |
|---|---|
| September 30, 2022 | -14.17M |
| June 30, 2022 | -14.64M |
| March 31, 2022 | -15.83M |
| December 31, 2021 | -13.01M |
| September 30, 2021 | -10.18M |
| June 30, 2021 | -12.96M |
| March 31, 2021 | -12.51M |
| December 31, 2020 | -9.297M |
| September 30, 2020 | -3.86M |
| June 30, 2020 | -11.91M |
| March 31, 2020 | -7.163M |
| December 31, 2019 | -4.669M |
| September 30, 2019 | -4.335M |
| June 30, 2019 | -5.571M |
| March 31, 2019 | -6.128M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 22.76M |
| Total Expenses (Quarterly) | 32.84M |
| EPS Diluted (Quarterly) | -0.2374 |
| Enterprise Value | 78.70M |
| Gross Profit Margin (Quarterly) | 77.53% |
| Profit Margin (Quarterly) | -44.30% |
| Earnings Yield | -63.17% |
| Normalized Earnings Yield | -63.17 |